One morning briefing that replaces the first ninety minutes of an MSL's day: what changed in your literature, who you're seeing, and what you owe from yesterday. Scoped to your therapeutic area and your KOL portfolio.
Rendered from the epilepsy demo configuration. Clinician names are fictional demo data.
MSLs are PharmDs and PhDs. The product treats them that way: it prepares, it does not track.
Continuous ingestion from PubMed, medRxiv, ClinicalTrials.gov, Semantic Scholar, ORCID, and DailyMed. Each item is summarized and scored for relevance to your therapeutic area and the KOLs you manage, so the briefing surfaces the handful of papers that matter instead of a feed of everything.
Before each interaction: the KOL's recent publications and trials, your prior discussion topics, and open follow-ups, in one view. Preparation that used to mean six browser tabs and a spreadsheet.
Structured capture of insights after each interaction, designed to take minutes. Insights roll up into an aggregate feed so medical affairs leadership sees field intelligence as it forms.
Directors see team coverage, insight themes, and aggregate activity. They do not see individual performance dashboards. That boundary is deliberate, and it is enforced in the API.
Individual data is visible only to the individual and their direct manager. Aggregate views require a minimum cohort of five people before anything is shown to leadership, which prevents re-identification of any one MSL.
These rules are enforced at the API layer with row-level security on every query, not just hidden in the interface. Every tenant's data is isolated. This is the trust mechanism that makes field teams actually use the product.
Demos run on live data scoped to a disease area you name. Pilot deployments are available now.